Clinical Trial: A LOW-COST VIRTUAL REALITY GAMING PLATFORM FOR NEUROREHABILITATION OF HEMIPARESIS

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title:

Brief Summary: Randomized waitlist control trial. One group will receive treatment immediately (50%) and the other group will receive treatment following a three-week delay (50%). Group 1 will be assessed by physical/occupational therapists and rehabilitation psychologists (blinded to treatment phase) before and after the virtual gaming treatment. Group 2 will receive two baseline assessments (baseline followed by three weeks of usual and customary care and then another baseline before starting the gaming treatment), and again after three weeks of virtual gaming treatment.

Detailed Summary:
Sponsor: Ohio State University

Current Primary Outcome:

• Bilateral Activity Monitors (Accelerometers) [ Time Frame: 0 to 1 Months ]
  Devices to monitor upper extremity movement throughout treatment
• Wolf Motor Function Test [ Time Frame: 0 to 1 Months ]
  Assessment to evaluate motor function

Original Primary Outcome: Same as current

Current Secondary Outcome:

• Biomechanical Measures [ Time Frame: 0 to 1 Months ]
  Recorded during game play through limb activation device and Kinect
• Multiple Sclerosis Impact Scale (MSIS-29) [ Time Frame: 0 to 1 Months ]
  Scale to asses living with MS
• Short form-36 Health Survey [ Time Frame: 0 to 1 Months ]
  Survey
• Neuro-QOL [ Time Frame: 0 to 1 Months ]
  Assessment to measure quality of life
• Patient Health Questionnaire (PHQ-9) [ Time Frame: 0 to 1 Months ]
• Montreal Cognitive Assessment (MoCA) [ Time Frame: 0 to 1 Months ]
  Assessment to measure cognitive function

Original Secondary Outcome: Same as current

Information By: Ohio State University

Dates:
Date Received: March 23, 2017
Date Started: November 2015
Date Completion: October 2018
Last Updated: March 23, 2017
Last Verified: March 2017